title: Mg++ deficient 11

status: Public on Aug 11 2006

type: RNA

city: East Hanover

first: Anthony

last: Masiello

state: NJ

address: One Health Plaza

country: USA

institute: Novartis

description:
Sample was taken at necropsy and RNA was extracted using a Trizol followed by RNeasy cleanup. Targets were produced using standard Affymetrix procedures from approximately 5 microgram of total RNA.
Keywords = Rattus norvegicus, liver, Mg++ deficient

molecule: total RNA

organism: Rattus norvegicus

source_name: Left lateral lobe of liver


title: Mg++ deficient 14


title: Standard diet 8

description:
Sample was taken at necropsy and RNA was extracted using a Trizol followed by RNeasy cleanup. Targets were produced using standard Affymetrix procedures from approximately 5 microgram of total RNA.
Keywords = Rattus norvegicus, liver, standard diet


title: Standard diet 10


title: Mg++ deficient 12


title: MG++ supplemented 4

description:
Sample was taken at necropsy and RNA was extracted using a Trizol followed by RNeasy cleanup. Targets were produced using standard Affymetrix procedures from approximately 5 microgram of total RNA.
Keywords = Rattus norvegicus, liver, MG++ supplemented


title: Standard diet 6


title: Standard diet 7


title: Standard diet 9


title: Mg++ deficient 13


title: MG++ supplemented 5


title: MG++ supplemented 3


title: Expression profile of ATL-Normal3-resting-B

status: Public on Jun 14 2006

city: Shimotsukeshi

first: Hiroyuki

last: Mano

state: Tochigi

address: 3311-1 Yakushiji

department: Division of Functional Genomics

country: Japan

institute: Jichi Medical University

description: CD4-positive T-cells were purified from peripheral blood of the patients. Total RNA was extracted by RNeasy mini spin column (Qiagen, Inc).

organism: Homo sapiens


title: MG++ supplemented 1


title: MG++ supplemented 2


title: Expression profile of ATL-Normal2-resting-A


title: Expression profile of ATL-Normal3-resting-A


title: Expression profile of ATL-Normal2-PHA-B


title: Expression profile of ATL-Normal3-PHA-B


title: Expression profile of ATL-Normal2-resting-B


title: Expression profile of ATL-Normal1-PHA-B


title: Expression profile of ATL-Normal1-resting-B


title: Expression profile of ATL-Normal3-PHA-A


title: Expression profile of ATL-Normal1-resting-A


title: Expression profile of ATL-70 patient-B

description: CD4-positive ATL cells were purified from peripheral blood of the patients. Total RNA was extracted by RNeasy mini spin column (Qiagen, Inc).


title: Expression profile of ATL-70 patient-A


title: Expression profile of ATL-68 patient-B


title: Expression profile of ATL-Normal2-PHA-A

description: CD4-positive T-cells were purified from peripheral blood ofthe patients. Total RNA was extracted by RNeasy mini spin column (Qiagen, Inc).


title: Expression profile of ATL-Normal1-PHA-A


title: Expression profile of ATL-68 patient-A


title: Expression profile of ATL-67 patient-B


title: Expression profile of ATL-65 patient-A


title: Expression profile of ATL-65 patient-B


title: Expression profile of ATL-67 patient-A


title: Expression profile of ATL-61 patient-B


title: Expression profile of ATL-63 patient-A


title: Expression profile of ATL-63 patient-B


title: Expression profile of ATL-66 patient-A


title: Expression profile of ATL-61 patient-A


title: Expression profile of ATL-60 patient-B


title: Expression profile of ATL-60 patient-A


title: Expression profile of ATL-54 patient-B


title: Expression profile of ATL-59 patient-B


title: Expression profile of ATL-57 patient-A


title: Expression profile of ATL-59 patient-A


title: Expression profile of ATL-58 patient-A


title: Expression profile of ATL-58 patient-B


title: Expression profile of ATL-57 patient-B


title: Expression profile of ATL-54 patient-A


title: Expression profile of ATL-53 patient-B


title: Expression profile of ATL-53 patient-A


title: Expression profile of ATL-51 patient-B


title: Expression profile of ATL-52 patient-A


title: Expression profile of ATL-50 patient-B


title: Expression profile of ATL-51 patient-A


title: Expression profile of ATL-50 patient-A


title: Expression profile of ATL-52 patient-B


title: Expression profile of ATL-48 patient-A


title: Expression profile of ATL-45 patient-A


title: Expression profile of ATL-48 patient-B


title: Expression profile of ATL-49 patient-A


title: Expression profile of ATL-49 patient-B


title: Expression profile of ATL-44 patient-B


title: Expression profile of ATL-46 patient-B


title: Expression profile of ATL-44 patient-A


title: Expression profile of ATL-43 patient-B


title: Expression profile of ATL-41 patient-A


title: Expression profile of ATL-46 patient-A


title: Expression profile of ATL-45 patient-B


title: Expression profile of ATL-43 patient-A


title: Expression profile of ATL-40 patient-B


title: Expression profile of ATL-40 patient-A


title: Expression profile of ATL-21 patient-B


title: Expression profile of ATL-33 patient-B


title: Expression profile of ATL33 patient-A


title: Expression profile of ATL-41 patient-B


title: Expression profile of ATL-21 patient-A


title: Expression profile of ATL-19 patient-B


title: Expression profile of ATL-19 patient-A


title: Expression profile of ATL-16 patient-B


title: Expression profile of ATL-16 patient-A


title: Expression profile of ATL-17 patient-B


title: Expression profile of ATL-12 patient-B


title: Expression profile of ATL-14 patient-A


title: Expression profile of ATL-15 patient-A


title: Expression profile of ATL-14 patient-B


title: Expression profile of ATL-09 patient-A


title: Expression profile of ATL-12 patient-A


title: Expression profile of ATL-10 patient-A


title: Expression profile of ATL-15 patient-B


title: Expression profile of ATL-17 patient-A


title: Expression profile of ATL-09 patient-B


title: Expression profile of ATL-10 patient-B


title: Expression profile of ATL-08 patient-B


title: Expression profile of ATL-06 patient-B


title: Expression profile of ATL-06 patient-A


title: Expression profile of ATL-05 patient-A


title: Expression profile of ATL-66 patient-B


title: Expression profile of ATL-03 patient-B


title: Expression profile of ATL-04 patient-B


title: Expression profile of ATL-03 patient-A


title: Expression profile of ATL-05 patient-B


title: Expression profile of ATL-08 patient-A


title: Expression profile of ATL-04 patient-A


title: Expression profile of ATL-02 patient-B


title: Expression profile of ATL-01 patient-B

description:
CD4-positive ATL cells were purified from peripheral blood of the patients. Total RNA was extracted by RNeasy mini spin column (Qiagen,
Inc).


title: Expression profile of Blast Bank ID 421B

status: Public on May 25 2006

description: CD133-positive immature blasts were purified from bone marrow of the patients. Total RNA was extracted by RNeasy mini spin column (Qiagen, Inc).

source_name: Blast Bank ID 421


title: Expression profile of ATL-02 patient-A


title: Expression profile of Blast Bank ID 427B

source_name: Blast Bank ID 427


title: Expression profile of Blast Bank ID 427


title: Expression profile of Blast Bank ID 416B

source_name: Blast Bank ID 416


title: Expression profile of Blast Bank ID 416


title: Expression profile of ATL-01 patient-A


title: Expression profile of Blast Bank ID 410B

source_name: Blast Bank ID 410


title: Expression profile of Blast Bank ID 418

source_name: Blast Bank ID 418


title: Expression profile of Blast Bank ID 409

source_name: Blast Bank ID 409


title: Expression profile of Blast Bank ID 430B

source_name: Blast Bank ID 430


title: Expression profile of Blast Bank ID 421


title: Expression profile of Blast Bank ID 395B

source_name: Blast Bank ID 395


title: Expression profile of Blast Bank ID 418B


title: Expression profile of Blast Bank ID 415B

source_name: Blast Bank ID 415


title: Expression profile of Blast Bank ID 402B

source_name: Blast Bank ID 402


title: Expression profile of Blast Bank ID 414

source_name: Blast Bank ID 414


title: Expression profile of Blast Bank ID 415


title: Expression profile of Blast Bank ID 414B


title: Expression profile of Blast Bank ID 413

source_name: Blast Bank ID 413


title: Expression profile of Blast Bank ID 413B


title: Expression profile of Blast Bank ID 410


title: Expression profile of Blast Bank ID 378B

source_name: Blast Bank ID 378


title: Expression profile of Blast Bank ID 379

source_name: Blast Bank ID 379


title: Expression profile of Blast Bank ID 382B

source_name: Blast Bank ID 382


title: Expression profile of Blast Bank ID 409B


title: Expression profile of Blast Bank ID 402


title: Expression profile of Blast Bank ID 378


title: Expression profile of Blast Bank ID 363

source_name: Blast Bank ID 363


title: Expression profile of Blast Bank ID 388

source_name: Blast Bank ID 388


title: Expression profile of Blast Bank ID 395


title: Expression profile of Blast Bank ID 388B


title: Expression profile of Blast Bank ID 385B

source_name: Blast Bank ID 385


title: Expression profile of Blast Bank ID 362

source_name: Blast Bank ID 362


title: Expression profile of Blast Bank ID 382


title: Expression profile of Blast Bank ID 430


title: Expression profile of Blast Bank ID 380

source_name: Blast Bank ID 380


title: Expression profile of Blast Bank ID 362B


title: Expression profile of Blast Bank ID 385


title: Expression profile of Blast Bank ID 363B


title: Expression profile of Blast Bank ID 380B


title: Expression profile of Blast Bank ID 355

source_name: Blast Bank ID 355


title: Expression profile of Blast Bank ID 376B

source_name: Blast Bank ID 376


title: Expression profile of Blast Bank ID 375B

source_name: Blast Bank ID 375


title: Expression profile of Blast Bank ID 375


title: Expression profile of Blast Bank ID 329B

source_name: Blast Bank ID 329


title: Expression profile of Blast Bank ID 376


title: Expression profile of Blast Bank ID 379B


title: Expression profile of Blast Bank ID 326B

source_name: Blast Bank ID 326


title: Expression profile of Blast Bank ID 349

source_name: Blast Bank ID 349


title: Expression profile of Blast Bank ID 349B


title: Expression profile of Blast Bank ID 321

source_name: Blast Bank ID 321


title: Expression profile of Blast Bank ID 325

source_name: Blast Bank ID 325


title: Expression profile of Blast Bank ID 355B


title: Expression profile of Blast Bank ID 319B

source_name: Blast Bank ID 319


title: Expression profile of Blast Bank ID 318B

source_name: Blast Bank ID 318


title: Expression profile of Blast Bank ID 326


title: Expression profile of Blast Bank ID 316B

source_name: Blast Bank ID 316


title: Expression profile of Blast Bank ID 339

source_name: Blast Bank ID 339


title: Expression profile of Blast Bank ID 321B


title: Expression profile of Blast Bank ID 347

source_name: Blast Bank ID 347


title: Expression profile of Blast Bank ID 347B


title: Expression profile of Blast Bank ID 339B


title: Expression profile of Blast Bank ID 316


title: Expression profile of Blast Bank ID 338

source_name: Blast Bank ID 338


title: Expression profile of Blast Bank ID 315

source_name: Blast Bank ID 315


title: Expression profile of Blast Bank ID 338B


title: Expression profile of Blast Bank ID 329


title: Expression profile of Blast Bank ID 325B


title: Expression profile of Blast Bank ID 318


title: Expression profile of Blast Bank ID 314

source_name: Blast Bank ID 314


title: Expression profile of Blast Bank ID 317

source_name: Blast Bank ID 317


title: Expression profile of Blast Bank ID 319


title: Expression profile of Blast Bank ID 310

source_name: Blast Bank ID 310


title: Expression profile of Blast Bank ID 317B


title: Expression profile of Blast Bank ID 310B


title: Expression profile of Blast Bank ID 315B


title: Expression profile of Blast Bank ID 313B

source_name: Blast Bank ID 313


title: Expression profile of Blast Bank ID 314B


title: Expression profile of Blast Bank ID 305B

source_name: Blast Bank ID 305


title: Expression profile of Blast Bank ID 292B

source_name: Blast Bank ID 292


title: Expression profile of Blast Bank ID 279

source_name: Blast Bank ID 279


title: Expression profile of Blast Bank ID 292


title: Expression profile of Blast Bank ID 280B

source_name: Blast Bank ID 280


title: Expression profile of Blast Bank ID 313


title: Expression profile of Blast Bank ID 305


title: Expression profile of Blast Bank ID 288B

source_name: Blast Bank ID 288


title: Expression profile of Blast Bank ID 306

source_name: Blast Bank ID 306


title: Expression profile of Blast Bank ID 279B


title: Expression profile of Blast Bank ID 280


title: Expression profile of Blast Bank ID 276B

source_name: Blast Bank ID 276


title: Expression profile of Blast Bank ID 306B


title: Expression profile of Blast Bank ID 275

source_name: Blast Bank ID 275


title: Expression profile of Blast Bank ID 276


title: Expression profile of Blast Bank ID 272B

source_name: Blast Bank ID 272


title: Expression profile of Blast Bank ID 288


title: Expression profile of Blast Bank ID 278B

source_name: Blast Bank ID 278


title: Expression profile of Blast Bank ID 277

source_name: Blast Bank ID 277


title: Expression profile of Blast Bank ID 277B


title: Expression profile of Blast Bank ID 272


title: Expression profile of Blast Bank ID 274B

source_name: Blast Bank ID 274


title: Expression profile of Blast Bank ID 274


title: Expression profile of Blast Bank ID 278


title: Expression profile of Blast Bank ID 270B

source_name: Blast Bank ID 270


title: Expression profile of Blast Bank ID 275B


title: Expression profile of Blast Bank ID 269B

source_name: Blast Bank ID 269


title: Expression profile of Blast Bank ID 265B

source_name: Blast Bank ID 265


title: Expression profile of Blast Bank ID 270


title: Expression profile of Blast Bank ID 267B

source_name: Blast Bank ID 267


title: Expression profile of Blast Bank ID 267


title: Expression profile of Blast Bank ID 269


title: Expression profile of Blast Bank ID 265


title: Expression profile of Blast Bank ID 262B

source_name: Blast Bank ID 262


title: Expression profile of Blast Bank ID 266

source_name: Blast Bank ID 266


title: Expression profile of Blast Bank ID 266B


title: Expression profile of Blast Bank ID 234B

source_name: Blast Bank ID 234


title: Expression profile of Blast Bank ID 262


title: Expression profile of Blast Bank ID 243

source_name: Blast Bank ID 243


title: Expression profile of Blast Bank ID 239

source_name: Blast Bank ID 239


title: Expression profile of Blast Bank ID 215

source_name: Blast Bank ID 215


title: Expression profile of Blast Bank ID 226B

source_name: Blast Bank ID 226


title: Expression profile of Blast Bank ID 205

source_name: Blast Bank ID 205


title: Expression profile of Blast Bank ID 227

source_name: Blast Bank ID 227


title: Expression profile of Blast Bank ID 195B

source_name: Blast Bank ID 195


title: Expression profile of Blast Bank ID 239B


title: Expression profile of Blast Bank ID 226


title: Expression profile of Blast Bank ID 243B


title: Expression profile of Blast Bank ID 234


title: Expression profile of Blast Bank ID 227B


title: Expression profile of Blast Bank ID 188B

source_name: Blast Bank ID 188


title: Expression profile of Blast Bank ID 180B

source_name: Blast Bank ID 180


title: Expression profile of Blast Bank ID 188


title: Expression profile of Blast Bank ID 183

source_name: Blast Bank ID 183


title: Expression profile of Blast Bank ID 215B


title: Expression profile of Blast Bank ID 183B


title: Expression profile of Blast Bank ID 195


title: Expression profile of Blast Bank ID 154B

source_name: Blast Bank ID 154


title: Expression profile of Blast Bank ID 148B

source_name: Blast Bank ID 148


title: Expression profile of Blast Bank ID 205B


title: Expression profile of Blast Bank ID 180


title: Expression profile of Blast Bank ID 142B

source_name: Blast Bank ID 142


title: Expression profile of Blast Bank ID 174B

source_name: Blast Bank ID 174


title: Expression profile of Blast Bank ID 174


title: Expression profile of Blast Bank ID 154


title: Expression profile of Blast Bank ID 109B

source_name: Blast Bank ID 109


title: Expression profile of Blast Bank ID 148


title: Expression profile of Blast Bank ID 107

source_name: Blast Bank ID 107


title: Expression profile of Blast Bank ID 093B

source_name: Blast Bank ID 093


title: Expression profile of Blast Bank ID 127B

source_name: Blast Bank ID 127


title: Expression profile of Blast Bank ID 142


title: Expression profile of Blast Bank ID 139B

source_name: Blast Bank ID 139


title: Expression profile of Blast Bank ID 098B

source_name: Blast Bank ID 098


title: Expression profile of Blast Bank ID 083B

source_name: Blast Bank ID 083


title: Expression profile of Blast Bank ID 098


title: Expression profile of Blast Bank ID 104

source_name: Blast Bank ID 104


title: Expression profile of Blast Bank ID 127


title: Expression profile of Blast Bank ID 107B


title: Expression profile of Blast Bank ID 087

source_name: Blast Bank ID 087


title: Expression profile of Blast Bank ID 093


title: Expression profile of Blast Bank ID 083


title: Expression profile of Blast Bank ID 104B


title: Expression profile of Blast Bank ID 109


title: Expression profile of Blast Bank ID 077

source_name: Blast Bank ID 077


title: Expression profile of Blast Bank ID 054B

source_name: Blast Bank ID 054


title: Expression profile of Blast Bank ID 066B

source_name: Blast Bank ID 066


title: Expression profile of Blast Bank ID 077B


title: Expression profile of Blast Bank ID 051B

source_name: Blast Bank ID 051


title: Expression profile of Blast Bank ID 087B


title: Expression profile of Blast Bank ID 066


title: Expression profile of Blast Bank ID 139


title: Expression profile of Blast Bank ID 063B

source_name: Blast Bank ID 063


title: Expression profile of Blast Bank ID 076B

source_name: Blast Bank ID 076


title: Expression profile of Blast Bank ID 045B

source_name: Blast Bank ID 045


title: Expression profile of Blast Bank ID 054


title: Expression profile of Blast Bank ID 042B

source_name: Blast Bank ID 042


title: Expression profile of Blast Bank ID 063


title: Expression profile of Blast Bank ID 036B

source_name: Blast Bank ID 036


title: Expression profile of Blast Bank ID 028B

source_name: Blast Bank ID 028


title: Expression profile of Blast Bank ID 046B

source_name: Blast Bank ID 046


title: Expression profile of Blast Bank ID 027B

source_name: Blast Bank ID 027


title: Expression profile of Blast Bank ID 062

source_name: Blast Bank ID 062


title: Expression profile of Blast Bank ID 051


title: Expression profile of Blast Bank ID 046


title: Expression profile of Blast Bank ID 062B


title: Expression profile of Blast Bank ID 032

source_name: Blast Bank ID 032


title: Expression profile of Blast Bank ID 023B

source_name: Blast Bank ID 023


title: Expression profile of Blast Bank ID 035

source_name: Blast Bank ID 035


title: Expression profile of Blast Bank ID 032B


title: Expression profile of Blast Bank ID 026

source_name: Blast Bank ID 026


title: Expression profile of Blast Bank ID 036


title: Expression profile of Blast Bank ID 035B


title: Expression profile of Blast Bank ID 026B


title: Expression profile of Blast Bank ID 076


title: Expression profile of Blast Bank ID 045


title: Expression profile of Blast Bank ID 028


title: Expression profile of Blast Bank ID 020B

source_name: Blast Bank ID 020


title: Expression profile of Blast Bank ID 027


title: Expression profile of Blast Bank ID 042


title: Expression profile of AML patient

source_name: Blast Bank ID 20


title: Expression profile of Blast Bank ID 23

source_name: Blast Bank ID 23


title: 7

status: Public on May 18 2006

type: genomic

city: Brisbane

first: Gareth

last: Price

state: Queensland

address: Carmody Road

country: Australia

institute: Queensland Facility for Advanced Bioinformatics

description: For sample information see "High-Density, Genome-Wide Linkage and Gene Copy Number Analyses of a Six-Generation Prostate Cancer Family." by Fitzgerald et al, Cancer Research.

molecule: genomic DNA

source_name: 7 LCM captured tumour DNA

source_name: 7 LCM captured adjacent normal DNA


title: 8

source_name: 8 LCM captured tumour DNA

source_name: 8 LCM captured adjacent normal DNA


title: 9

source_name: 9 LCM captured tumour DNA

source_name: 9 LCM captured adjacent normal DNA


title: 3

source_name: 3 LCM captured tumour DNA

source_name: 3 LCM captured adjacent normal DNA


title: 14

source_name: 14 LCM captured tumour DNA

source_name: 14 LCM captured adjacent normal DNA


title: 20

source_name: 20 LCM captured tumour DNA


title: 4

source_name: 4 LCM captured tumour DNA

source_name: 4 LCM captured adjacent normal DNA


title: 1

source_name: 1 LCM captured tumour DNA

source_name: 1 LCM captured adjacent normal DNA


title: 5

source_name: 5 LCM captured tumour (PIN) DNA

source_name: 5 LCM captured adjacent normal DNA


title: 15

source_name: 15 LCM captured tumour DNA

source_name: 15 LCM captured adjacent normal DNA


title: 16

source_name: 16 LCM captured tumour DNA

source_name: 16 LCM captured adjacent normal DNA


title: 2

source_name: 2 LCM captured tumour DNA

source_name: 2 LCM captured adjacent normal DNA


title: 13

source_name: 13 LCM captured tumour DNA


title: 18

source_name: 18 LCM captured tumour DNA

source_name: 18 LCM captured adjacent normal DNA


title: 132

source_name: 132 LCM captured tumour DNA

source_name: 132 LCM captured adjacent normal DNA


title: 12

source_name: 12 LCM captured tumour DNA

source_name: 12 LCM captured adjacent normal DNA


title: 919AC - Cord

status: Public on May 19 2006

city: Stanford

first: Andrew

middle: Yuan

last: Zhang

state: CA

address: 770 Welch Rd, Fourth floor

department: Plastic and Reconstructive Surgery

institute: Stanford Hospital and Clinics

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2003-02/38058.gif; format: GIF

source_name: Cy3 - channel 1 - Universal RNA

source_name: Cy5 - channel 2 - 919AC - Cord


title: NOS exp2 NMDA

status: Public on Apr 26 2006

city: Baltimore

first: Ted

middle: M

last: Dawson

state: MD

address: 733 N. Broadway, MRB SUITE 731

department: Institute for Cell Engineering

institute: Johns Hopkins University School of Medicine

description: embryonic cortical neuron treated with NMDA

source_name: rat cortical neuron


title: NOS exp1 NitroArg

description: embryonic cortical neuron treated with NMDA and NitroArginine


title: NOS exp2 NitroArg

description: embryonic cortical neuron treated with NMDA and Nitroarginine


title: NOS exp1 NMDA


title: 919BF - Fascia

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2003-02/38064.gif; format: GIF

source_name: Cy5 - channel 2 - 919BF - Fascia


title: NOS exp1 control

description: embryonic cortical neuron treated with CSS


title: wild-type control

description: adult wild-type mouse littermate (c57bl) brain cortex

organism: Mus musculus

source_name: brain cortex


title: Mek exp2 NMDA


title: nNOS KO

description: adult nNOS Knockout mouse (c57bl) brain cortex


title: Mek exp2 PD98059

description: embryonic cortical neuron treated with NMDA and PD98059


title: white adipose tissue from C57BL/6J mice treated with CL-316,243 (No.2)

status: Public on May 17 2006

city: Baton Rouge

first: Xiaotuan

last: Liu

state: LA

address: 6400 Perkins Rd.

institute: Pennington Biomedical Research Center

description:
12 week old of C57BL/6J mice were divided into two groups (6 mice/group) and injected with either saline (SALINE3HR) or 1mg/Kg body weight of CL316,246 (CL3HR). The mice were sacrificed by decapitation at 3hr after treatment. Epididymal fat depots were dissected out and immediately frozen in liquid nitrogen. Total RNA was extracted by homogenizing frozen tissue in Trizol Reagent (Molecular Research Center Inc., Cincinnati, Ohio) and treated with DNase I (Invitrogen, Carlsbad, CA). Equal amounts of RNA was pooled from individual samples and converted to cDNA that was labeled by Fluorescein (Cy-3) or Biotin (Cy-5) and detected by using a tyramide signal amplification (TSA) labeling and detection kit (Perkin-Elmer, Boston, MA). Array hybridizations were performed as described in the instruction manual (MICROMAX TSA Labeling and Detection kit, Perkin-Elmer, Boston, MA). After hybridization, slides were scanned using a GSI Lumonics ScanArray 5000 (Packard Biochip Technologies; Meriden, CT) and expression data analyzed with QuantArray V3.0 software (Packard Bioscience; Meriden, CT). A uniform scale factor was applied to normalize signal intensities between Cy5 and Cy3. Locally weighted regression and scatter plot smoothing (LOWESS) was applied to account for dye variation between slides, and for signal intensity effects. An in-house software program was used to perform this analysis. Details of the algorithm can be found at http://bioinfo.pbrc.edu.
Keywords = White adipose tissue
Keywords = CL-316
Keywords = 243
Keywords = C57BL/6J
Lot batch = PBRC M6-54

source_name: pooled samples (6males) treated with CL-316,243 for 3 hours (CL3HR)

source_name: pooled samples (6 males) treated with saline for 3 hours (SALINE3HR)


title: 120503 - Cord

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2004-04/51397.gif; format: GIF

source_name: Cy5 - channel 2 - 120503 - Cord


title: NOS exp2 CONTROL


title: 011604 -CTR

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2004-04/51402.gif; format: GIF

source_name: Cy5 - channel 2 - 011604 -CTR


title: white adipose tissue from C57BL/6J mice treated with CL-316,243 (No.4)

description:
12 week old of C57BL/6J mice were divided into two groups (6 mice/group) and injected with either saline (SALINE3HR) or 1mg/Kg body weight of CL316,246 (CL3HR). The mice were sacrificed by decapitation at 3hr after treatment. Epididymal fat depots were dissected out and immediately frozen in liquid nitrogen. Total RNA was extracted by homogenizing frozen tissue in Trizol Reagent (Molecular Research Center Inc., Cincinnati, Ohio) and treated with DNase I (Invitrogen, Carlsbad, CA). Equal amounts of RNA was pooled from individual samples and converted to cDNA that was labeled by Fluorescein (Cy-3) or Biotin (Cy-5) and detected by using a tyramide signal amplification (TSA) labeling and detection kit (Perkin-Elmer, Boston, MA). Array hybridizations were performed as described in the instruction manual (MICROMAX TSA Labeling and Detection kit, Perkin-Elmer, Boston, MA). After hybridization, slides were scanned using a GSI Lumonics ScanArray 5000 (Packard Biochip Technologies; Meriden, CT) and expression data analyzed with QuantArray V3.0 software (Packard Bioscience; Meriden, CT). A uniform scale factor was applied to normalize signal intensities between Cy5 and Cy3. Locally weighted regression and scatter plot smoothing (LOWESS) was applied to account for dye variation between slides, and for signal intensity effects. An in-house software program was used to perform this analysis. Details of the algorithm can be found at http://bioinfo.pbrc.edu.
Lot batch = PBRC M6-56


title: 120503 - Fascia

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2004-04/51398.gif; format: GIF

source_name: Cy5 - channel 2 - 120503 - Fascia


title: 1206F - Fascia

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2003-02/38066.gif; format: GIF

source_name: Cy5 - channel 2 - 1206F - Fascia


title: Mek exp1 PD98059


title: Mek exp1 NMDA


title: 1206C - Cord

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2003-02/38065.gif; format: GIF

source_name: Cy5 - channel 2 - 1206C - Cord


title: Mek exp2 control


title: white adipose tissue from C57BL/6J mice treated with CL-316,243 (No.5)

description:
12 week old of C57BL/6J mice were divided into two groups (6 mice/group) and injected with either saline (SALINE3HR) or 1mg/Kg body weight of CL316,246 (CL3HR). The mice were sacrificed by decapitation at 3hr after treatment. Epididymal fat depots were dissected out and immediately frozen in liquid nitrogen. Total RNA was extracted by homogenizing frozen tissue in Trizol Reagent (Molecular Research Center Inc., Cincinnati, Ohio) and treated with DNase I (Invitrogen, Carlsbad, CA). Equal amounts of RNA was pooled from individual samples and converted to cDNA that was labeled by Fluorescein (Cy-3) or Biotin (Cy-5) and detected by using a tyramide signal amplification (TSA) labeling and detection kit (Perkin-Elmer, Boston, MA). Array hybridizations were performed as described in the instruction manual (MICROMAX TSA Labeling and Detection kit, Perkin-Elmer, Boston, MA). After hybridization, slides were scanned using a GSI Lumonics ScanArray 5000 (Packard Biochip Technologies; Meriden, CT) and expression data analyzed with QuantArray V3.0 software (Packard Bioscience; Meriden, CT). A uniform scale factor was applied to normalize signal intensities between Cy5 and Cy3. Locally weighted regression and scatter plot smoothing (LOWESS) was applied to account for dye variation between slides, and for signal intensity effects. An in-house software program was used to perform this analysis. Details of the algorithm can be found at http://bioinfo.pbrc.edu.
Keywords = White adipose tissue
Keywords = CL-316
Keywords = 243
Keywords = C57BL/6J
Lot batch = PBRC M6-57


title: white adipose tissue from C57BL/6J mice treated with CL-316,243 (No.6)

description:
12 week old of C57BL/6J mice were divided into two groups (6 mice/group) and injected with either saline (SALINE3HR) or 1mg/Kg body weight of CL316,246 (CL3HR). The mice were sacrificed by decapitation at 3hr after treatment. Epididymal fat depots were dissected out and immediately frozen in liquid nitrogen. Total RNA was extracted by homogenizing frozen tissue in Trizol Reagent (Molecular Research Center Inc., Cincinnati, Ohio) and treated with DNase I (Invitrogen, Carlsbad, CA). Equal amounts of RNA was pooled from individual samples and converted to cDNA that was labeled by Fluorescein (Cy-3) or Biotin (Cy-5) and detected by using a tyramide signal amplification (TSA) labeling and detection kit (Perkin-Elmer, Boston, MA). Array hybridizations were performed as described in the instruction manual (MICROMAX TSA Labeling and Detection kit, Perkin-Elmer, Boston, MA). After hybridization, slides were scanned using a GSI Lumonics ScanArray 5000 (Packard Biochip Technologies; Meriden, CT) and expression data analyzed with QuantArray V3.0 software (Packard Bioscience; Meriden, CT). A uniform scale factor was applied to normalize signal intensities between Cy5 and Cy3. Locally weighted regression and scatter plot smoothing (LOWESS) was applied to account for dye variation between slides, and for signal intensity effects. An in-house software program was used to perform this analysis. Details of the algorithm can be found at http://bioinfo.pbrc.edu.
Keywords = White adipose tissue
Keywords = CL-316
Keywords = 243
Keywords = C57BL/6J
Lot batch = PBRC M6-58


title: 1101T- CTR

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2003-02/38067.gif; format: GIF

source_name: Cy5 - channel 2 - 1101T- CTR


title: 919BC - Cord

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2003-02/38063.gif; format: GIF

source_name: Cy5 - channel 2 - 919BC - Cord


title: white adipose tissue from C57BL/6J mice treated with CL-316,243 (No.3)

description:
12 week old of C57BL/6J mice were divided into two groups (6 mice/group) and injected with either saline (SALINE3HR) or 1mg/Kg body weight of CL316,246 (CL3HR). The mice were sacrificed by decapitation at 3hr after treatment. Epididymal fat depots were dissected out and immediately frozen in liquid nitrogen. Total RNA was extracted by homogenizing frozen tissue in Trizol Reagent (Molecular Research Center Inc., Cincinnati, Ohio) and treated with DNase I (Invitrogen, Carlsbad, CA). Equal amounts of RNA was pooled from individual samples and converted to cDNA that was labeled by Fluorescein (Cy-3) or Biotin (Cy-5) and detected by using a tyramide signal amplification (TSA) labeling and detection kit (Perkin-Elmer, Boston, MA). Array hybridizations were performed as described in the instruction manual (MICROMAX TSA Labeling and Detection kit, Perkin-Elmer, Boston, MA). After hybridization, slides were scanned using a GSI Lumonics ScanArray 5000 (Packard Biochip Technologies; Meriden, CT) and expression data analyzed with QuantArray V3.0 software (Packard Bioscience; Meriden, CT). A uniform scale factor was applied to normalize signal intensities between Cy5 and Cy3. Locally weighted regression and scatter plot smoothing (LOWESS) was applied to account for dye variation between slides, and for signal intensity effects. An in-house software program was used to perform this analysis. Details of the algorithm can be found at http://bioinfo.pbrc.edu.
Keywords = White adipose tissue
Keywords = CL-316
Keywords = 243
Keywords = C57BL/6J
Lot batch = PBRC M6-55


title: Mek exp1 control treatment

source_name: Rat cortical neuron


title: 010904B-CTR

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2004-04/51401.gif; format: GIF

source_name: Cy5 - channel 2 - 010904B-CTR


title: white adipose tissue from C57BL/6J mice treated with CL-316,243 (No.1)

description:
12 week old of C57BL/6J mice were divided into two groups (6 mice/group) and injected with either saline (SALINE3HR) or 1mg/Kg body weight of CL316,246 (CL3HR). The mice were sacrificed by decapitation at 3hr after treatment. Epididymal fat depots were dissected out and immediately frozen in liquid nitrogen. Total RNA was extracted by homogenizing frozen tissue in Trizol Reagent (Molecular Research Center Inc., Cincinnati, Ohio) and treated with DNase I (Invitrogen, Carlsbad, CA). Equal amounts of RNA was pooled from individual samples and converted to cDNA that was labeled by Fluorescein (Cy-3) or Biotin (Cy-5) and detected by using a tyramide signal amplification (TSA) labeling and detection kit (Perkin-Elmer, Boston, MA). Array hybridizations were performed as described in the instruction manual (MICROMAX TSA Labeling and Detection kit, Perkin-Elmer, Boston, MA). After hybridization, slides were scanned using a GSI Lumonics ScanArray 5000 (Packard Biochip Technologies; Meriden, CT) and expression data analyzed with QuantArray V3.0 software (Packard Bioscience; Meriden, CT). A uniform scale factor was applied to normalize signal intensities between Cy5 and Cy3. Locally weighted regression and scatter plot smoothing (LOWESS) was applied to account for dye variation between slides, and for signal intensity effects. An in-house software program was used to perform this analysis. Details of the algorithm can be found at http://bioinfo.pbrc.edu.
Keywords = White adipose tissue
Keywords = CL-316
Keywords = 243
Keywords = C57BL/6J
Lot batch = PBRC M6-53


title: 919AF - Fascia

description:
Simple annotation: Diseased tissue, human tissue
Image: http://genome-www5.stanford.edu/MicroArray/gifs/2003-02/38062.gif; format: GIF

source_name: Cy5 - channel 2 - 919AF - Fascia


title: Fayoumi 16 hours cecum

status: Public on Apr 23 2006

city: Ames

first: Susan

middle: J

last: Lamont

state: IA

address: 2255 Kildee Hall

department: Animal Science

institute: Iowa State University

description:
3 Fayoumi 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 16 hours
Keywords = Fayoumi SE cecum
Lot batch = slide 1743

organism: Gallus gallus

source_name: SE challenged

source_name: control


title: Leghorn 16 hours cecum

description:
3 Leghorn 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 16 hours
Keywords = Leghorn SE cecum
Lot batch = slide 1739


title: broiler 16 hours cecum

description:
3 broiler 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 16 hours
Keywords = broiler SE cecum
Lot batch = slide 1740

source_name: SE challenge


title: Fayoumi 2 hours spleen replicate

description:
3 Fayoumi 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 2 hours
Keywords = Fayoumi SE spleen
Lot batch = slide 51


title: MD regenerating cells

status: Public on Apr 13 2006

city: Potomac Falls

first: Agnieszka

middle: Maria

last: Lichanska

state: VA

institute: Tessarae, LLC

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (using Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mMD_R.
Keywords = Human, periodontal regeneration, markers of regeneration

source_name: regenerating cells


title: Fayoumi 2 hours cecum

description:
3 Fayoumi 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 2 hours
Keywords = Fayoumi SE cecum
Lot batch = slide 1736


title: Fayoumi 2 hours cecum replicate

description:
3 Fayoumi 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 2 hours
Keywords = Fayoumi SE cecum
Lot batch = slide 1787


title: CH ligament

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (using Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mCH_L.
Keywords = Human, periodontal regeneration, markers of regeneration

source_name: ligament


title: broiler 2 hours cecum

description:
3 broiler 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 2 hours
Keywords = broiler SE cecum
Lot batch = slide 1737


title: CH regenerating cells

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (using Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mCH_R.
Keywords = Human, periodontal regeneration, markers of regeneration


title: Leghorn 2 hours cecum replicate

description:
3 Leghorn 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 2 hours
Keywords = Leghorn SE cecum
Lot batch = slide 1789


title: broiler 2 hours spleen replicate

description:
3 broiler 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 2 hours
Keywords = broiler SE spleen
Lot batch = slide 52


title: Fayoumi 2 hours spleen

description:
Fayoumi 3 birds at day 1 challenged with SE, and 3 birds at day1 without challenge were hybridized into one slide. Spleen were collected after 2 hours post challenge
Keywords = Fayoumi
Keywords = spleen
Keywords = SE
Lot batch = slide 41

source_name: SE challanged


title: Leghorn 2 hours spleen replicate

description:
3 Leghorn 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 2 hours
Keywords = Leghorn SE spleen
Lot batch = slide 53


title: DB ligament

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (using Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mDB_L.
Keywords = Human, periodontal regeneration, markers of regeneration


title: Leghorn 2 hours cecum

description:
3 Leghorn 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 2 hours
Keywords = Leghorn SE cecum
Lot batch = slide 1735


title: Broiler 16 hours cecum replicate

description:
3 broiler 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 16 hours
Keywords = broiler SE cecum
Lot batch = slide 2528


title: broiler 2 hours cecum replicate

description:
3 broiler 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 2 hours
Keywords = broiler SE cecum
Lot batch = slide 1788


title: Leghorn, 2 hours spleen

description:
Leghorn G-B1 3 birds at day 1 challenged with SE, and 3 birds at day1 without challenge were hybridized into one slide. Spleen were collected after 2 hours post challenge
Keywords = Leghorn
Keywords = spleen
Keywords = SE
Lot batch = slide 40

source_name: Control


title: broiler 16 hours spleen replicate

description:
3 broiler 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 16 hours
Keywords = Broiler SE spleen
Lot batch = slide 50


title: Leghorn 16 hours cecum replicate

description:
3 Leghorn 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 16 hours
Keywords = Leghorn SE cecum
Lot batch = slide 1747


title: Leghorn 16 hours spleen replicate

description:
3 Leghorn 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 16 hours
Keywords = Leghorn SE spleen
Lot batch = slide 49


title: Fayoumi 16 hours spleen

description:
3 Fayoumi 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 16 hours
Keywords = Fayoumi SE spleen
Lot batch = slide 47


title: Leghorn 16 hours spleen

description:
3 Leghorn 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 16 hours
Keywords = Leghorn SE spleen
Lot batch = slide 45


title: Fayoumi 16 hours spleen replicate

description:
3 Fayoumi 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 16 hours
Keywords = Fayoumi SE spleen
Lot batch = slide 48

source_name: controll


title: DB regenerating cells

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (using Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mDB_R.
Keywords = Human, periodontal regeneration, markers of regeneration


title: Faoumi 16 hours cecum replicate

description:
3 Fayoumi 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Cecum tissue was taken after 16 hours
Keywords = Fayoumi SE cecum
Lot batch = slide 1744


title: Broiler 2 hours spleen

description:
Broiler 3 birds at day 1 challenged with SE, and 3 birds at day1 without challenge were hybridized into one slide. Spleen were collected after 2 hours post challenge
Keywords = Broiler
Keywords = spleen
Keywords = SE
Lot batch = slide 43


title: Broiler 16 hours spleen

description:
3 broiler 1-day-old birds challenged with SE were hybridized with 3 birds without SE challenged. Spleen tissue was taken after 16 hours
Keywords = broiler SE spleen
Lot batch = slide 46


title: MD ligament

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (using Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mMD_L
Keywords = Human, periodontal regeneration, markers of regeneration


title: CH gingiva

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (using Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mCH_G
Keywords = Human, periodontal regeneration, markers of regeneration

source_name: gingiva


title: DBA whole brain 3B

status: Public on Apr 05 2006

city: Aurora

first: Sanjiv

middle: Vijay

last: Bhave

state: CO

address: 12800 E. 19th Avenue

department: Pharmacology

institute: UCDHSC

description:
Whole brain was obtained from five 10 week old naive C57BL/2 male mice  and four 10 week old naive DBA/2J mice.  Total RNA was extracted using a Quiagen RNeasy kit midi kits for lipid rich tissues. Target cRNA were produced using standard Affymetrix procedures from 5 ug of total RNA.
This sample is also known as C57 1.
Keywords = Mus musculus, inbred strains, whole brain gene expression pattern

source_name: Whole brain


title: C57 whole brain 4B


title: DB gingiva

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (using Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mDB_G.
Keywords = Human, periodontal regeneration, markers of regeneration


title: DBA whole brain 4B


title: DBA whole brain 1B


title: 567.KO

status: Public on Apr 11 2006

city: Augusta

first: Ratanmani

last: Joshi

state: GA

address: Laney Walker Blvd

department: Genomics

institute: Center for Biotechnology and Genomic Medicine

description: TEC B6 vs Aire KO

source_name: mouse


title: 571.KO

description: TEC B6 vs Aire KO


title: C57 whole brain 5B


title: MD gingiva

description:
cells isolated from patients with periodontitis were grown in tissue culture and used between 4-6 passage. Total RNA was extracted using an Ambion RNaqueous RNA extraction kit. Targets were produced using Affymetrix procedure (with Enzo IVT kit) from 5ug of total RNA. 3 biological replicates were analysed per each group. Sample also known as mMD_G.
Keywords = Human, periodontal regeneration, markers of regeneration


title: C57 whole brain 3B


title: C57 whole brain 3A


title: C57 whole brain 4


title: DBA whole brain 2B


title: DBA whole brain 3A


title: DBA whole brain 2


title: DBA whole brain 3


title: 568.B6

description: TEC B6 vs Aire KO


title: 570.B6

description: TEC B6 vs Aire KO


title: C57 whole brain 3


title: C57 whole brain 5A


title: DBA whole brain 1A


title: C57 whole brain 5


title: C57 whole brain 4A


title: DBA whole brain 1


title: DBA whole brain 4


title: 569.KO

description: TEC B6 vs Aire KO


title: DBA whole brain 2A


title: 566.B6

description: KO vs B6


title: C57 whole brain 2B


title: C57 whole brain 1A


title: C57 whole brain 2A


title: C57 whole brain 1B


title: C57 whole brain 1


title: Mus musculus castaneus techrep1

status: Public on Apr 01 2006

city: Thuwal

first: Christian

middle: Robert

last: Voolstra

address: Red Sea Research Center

country: Saudi Arabia

institute: King Abdullah University of Science and Technology

description: RNA from testis tissue was hybridized on an affymetrix chip

source_name: testis


title: Mus musculus ssp techrep2


title: Mus musculus domesticus techrep1


title: Healthy tungstate-treated rats 2

city: Genève

first: Jordi

last: Altirriba

address: Rue Michel-Servet 1

department: Dpts de Médecine Interne et de Physiologie cellulaire et Métabolisme

country: Switzerland

institute: Centre Médical Universitaire de Genève

description:
Healthy rats were treated with sodium tunsgtate at a dose of 0.7g/L during one week, and at 2g/L during the next 4-5 weeks without observing any variation in its normoglycemia
Keywords = pancreas regeneration
Keywords = STZ
Keywords = diabetes
Keywords = tungstate
Keywords = insulin-like agents
Keywords = beta cell plasticity
Keywords = neogenesis

source_name: Pancreas


title: Diabetic untreated rats 1

description:
Diabetic (STZ) rats were maintained during 5-6 weeks, without observing any variation in its hyperglycaemia
Keywords = pancreas regeneration
Keywords = STZ
Keywords = diabetes
Keywords = tungstate
Keywords = insulin-like agents
Keywords = beta cell plasticity
Keywords = neogenesis


title: Mus musculus musculus techrep1


title: Healthy untreated rats 1

description:
Healthy rats were maintained during 5-6 weeks, without observing any variation in its normoglycaemia
Keywords = pancreas regeneration
Keywords = STZ
Keywords = diabetes
Keywords = tungstate
Keywords = insulin-like agents
Keywords = beta cell plasticity
Keywords = neogenesis


title: Mus musculus musculus techrep2


title: Diabetic untreated rats 3


title: Mus musculus ssp techrep1


title: Healthy untreated rats 2


title: Healthy untreated rats 3


title: Diabetic tungstate-treated rats 2

description:
Diabetic (STZ) rats were treated with sodium tunsgtate at a dose of 0.7g/L during one week, and at 2g/L during the next 4-5 weeks until his glycemia was reduced to a level near to the normoglycemia
Keywords = pancreas regeneration
Keywords = STZ
Keywords = diabetes
Keywords = tungstate
Keywords = insulin-like agents
Keywords = beta cell plasticity
Keywords = neogenesis


title: Healthy tungstate-treated rats 3


title: Diabetic tungstate-treated rats 3


title: Mus musculus castaneus techrep2


title: DBA whole brain 4A


title: Diabetic untreated rats 2


title: CGR8 mouse embryonic stem cells time-course experiment technical replicate

description: time-course experiment with embryoid bodies of CGR8 mouse embryonic stem cells ; in the whole time-series RNA from 0 days old embryoid bodies were hybridized against RNA from 3 days and 10 days old embryoid bodies

source_name: day 3 embryoid bodies CGR8 hanging drop

source_name: day 0 embryoid bodies CGR8 undifferentiated


title: CGR8 mouse embryonic stem cells time-course experiment


title: CGR8 mouse embryonic stem cells time-course experiment day0 vs day10

source_name: day 10 embryoid bodies CGR8 hanging drop


title: CGR8 mouse embryonic stem cells time-course experiment day0 vs day10 technical replicate


title: Mus musculus domesticus techrep2


title: SOY4

status: Public on Mar 22 2006

city: Riverside

first: Stephen

middle: R.

last: Spindler

department: Biochemistry

institute: University of California, Riverside

description:
Mice and diets.  One-month-old male mice of the long-lived B6C3F1 strain were purchased from Harlan (Indianapolis, IN) and maintained as described after weaning (15).  Mice were housed in groups of 4 per cage and fed a non-purified diet, PMI Nutrition International Product #5001 (Purina Mills, Richmond, IN).  At 5 months of age, the mice were individually housed, and randomly assigned to one of two groups, control (CON) or long-term CR (LTCR).  CON mice were fed 93 kcal per week of a defined control diet (AIN-93M, Diet No. F05312, BIO-SERV).  LTCR mice were fed 52.2 kcal per week of a defined CR diet (AIN-93M 40% Restricted, Diet No. F05314, BIO-SERV).  The LTCR mice consumed approximately 40% fewer calories than mice in the CON mice.  The CR diet was enriched so that the CR mice consumed approximately the same amount of protein, vitamins, and minerals per gram body weight as the control mice.  Experimental design.  At 20 months of age, cohorts of mice in the CON group were randomly assigned to one of 7 experimental groups (Fig. 1).  A CON group continued to be fed 93 kcal per week of control diet for 8 weeks.  A CR8 group was fed 77 kcal per week of CR diet for 2 weeks, followed by 52.2 kcal per week of CR diet for 6 weeks.  The remaining dietary groups were fed the control diets containing, respectively, metformin (MET; Sigma, St. Louis, MO), glipizide (GLIP; Sigma), GLIP plus MET (GM), rosiglitazone (ROS; Avandia, SmithKline Beecham) or soy isoflavone extract (SOY; NOVASOY 400, Life Extension Foundation) for 8 weeks at the dosages indicated in Table 1.  The drugs were mixed with powdered control diet and cold-pressed into one gram pellets (BIO-SERV Inc.).  At 0900, all mice were fed 2/7 of the weekly allotment of food on Monday and Wednesday and 3/7 on Friday.  The mice had free access to acidified tap water.  They were fasted for 48 hours and killed by cervical dislocation at 22 months of age.  No signs of pathology were detected in the animals used for the studies reported (n=4 per group).  Organs were removed rapidly, flash frozen, and stored in liquid nitrogen.  The weights of the mice were monitored bi-weekly.  Mouse weights are given in Table 1.
Keywords = CR mimetics
Keywords = microarray profiling
Keywords = drug discovery
Keywords = gene-expression biomarkers

source_name: liver


title: SOY3


title: SOY2


title: ROS4


title: ROS1


title: MET1


title: ROS3


title: Healthy tungstate-treated rats 1


title: MET3


title: MET4


title: SOY1


title: LTCR4


title: MET2


title: LTCR1


title: GM3


title: LTCR3


title: GM2


title: GLIP2

description:
Mice and diets.  One-month-old male mice of the long-lived B6C3F1 strain were purchased from Harlan (Indianapolis, IN) and maintained as described after weaning (15).  Mice were housed in groups of 4 per cage and fed a non-purified diet, PMI Nutrition International Product #5001 (Purina Mills, Richmond, IN).  At 5 months of age, the mice were individually housed, and randomly assigned to one of two groups, control (CON) or long-term CR (LTCR).  CON mice were fed 93 kcal per week of a defined control diet (AIN-93M, Diet No. F05312, BIO-SERV).  LTCR mice were fed 52.2 kcal per week of a defined CR diet (AIN-93M 40% Restricted, Diet No. F05314, BIO-SERV).  The LTCR mice consumed approximately 40% fewer calories than mice in the CON mice.  The CR diet was enriched so that the CR mice consumed approximately the same amount of protein, vitamins, and minerals per gram body weight as the control mice.  Experimental design.  At 20 months of age, cohorts of mice in the CON group were randomly assigned to one of 7 experimental groups (Fig. 1).  A CON group continued to be fed 93 kcal per week of control diet for 8 weeks.  A CR8 group was fed 77 kcal per week of CR diet for 2 weeks, followed by 52.2 kcal per week of CR diet for 6 weeks.  The remaining dietary groups were fed the control diets containing, respectively, metformin (MET; Sigma, St. Louis, MO), glipizide (GLIP; Sigma), MET plus GLIP, rosiglitazone (ROS; Avandia, SmithKline Beecham) or soy isoflavone extract (SOY; NOVASOY 400, Life Extension Foundation) for 8 weeks at the dosages indicated in Table 1.  The drugs were mixed with powdered control diet and cold-pressed into one gram pellets (BIO-SERV Inc.).  At 0900, all mice were fed 2/7 of the weekly allotment of food on Monday and Wednesday and 3/7 on Friday.  The mice had free access to acidified tap water.  They were fasted for 48 hours and killed by cervical dislocation at 22 months of age.  No signs of pathology were detected in the animals used for the studies reported (n=4 per group).  Organs were removed rapidly, flash frozen, and stored in liquid nitrogen.  The weights of the mice were monitored bi-weekly.  Mouse weights are given in Table 1.
Keywords = CR mimetics
Keywords = microarray profiling
Keywords = drug discovery
Keywords = gene-expression biomarkers


title: Diabetic tungstate-treated rats 1


title: CR8-2

description:
Mice and diets.  One-month-old male mice of the long-lived B6C3F1 strain were purchased from Harlan (Indianapolis, IN) and maintained as described after weaning (15).  Mice were housed in groups of 4 per cage and fed a non-purified diet, PMI Nutrition International Product #5001 (Purina Mills, Richmond, IN).  At 5 months of age, the mice were individually housed, and randomly assigned to one of two groups, control (CON) or long-term CR (LTCR).  CON mice were fed 93 kcal per week of a defined control diet (AIN-93M, Diet No. F05312, BIO-SERV).  LTCR mice were fed 52.2 kcal per week of a defined CR diet (AIN-93M 40% Restricted, Diet No. F05314, BIO-SERV).  The LTCR mice consumed approximately 40% fewer calories than mice in the CON mice.  The CR diet was enriched so that the CR mice consumed approximately the same amount of protein, vitamins, and minerals per gram body weight as the control mice.
Keywords = CR mimetics
Keywords = microarray profiling
Keywords = drug discovery
Keywords = gene-expression biomarkers


title: GLIP3


title: ROS2


title: GM4


title: GLIP4


title: CR8-1


title: CON4


title: CR8-4


title: CON 1

description:
One-month-old male mice of the long-lived B6C3F1 strain were purchased from Harlan (Indianapolis, IN) and maintained as described after weaning (15).  Mice were housed in groups of 4 per cage and fed a non-purified diet, PMI Nutrition International Product #5001 (Purina Mills, Richmond, IN).  At 5 months of age, the mice were individually housed, and randomly assigned to one of two groups, control (CON) or long-term CR (LTCR).  CON mice were fed 93 kcal per week of a defined control diet (AIN-93M, Diet No. F05312, BIO-SERV).  LTCR mice were fed 52.2 kcal per week of a defined CR diet (AIN-93M 40% Restricted, Diet No. F05314, BIO-SERV).  The LTCR mice consumed approximately 40% fewer calories than mice in the CON mice.  The CR diet was enriched so that the CR mice consumed approximately the same amount of protein, vitamins, and minerals per gram body weight as the control mice.
Experimental design.  At 20 months of age, cohorts of mice in the CON group were randomly assigned to one of 7 experimental groups (Fig. 1).  A CON group continued to be fed 93 kcal per week of control diet for 8 weeks.  A CR8 group was fed 77 kcal per week of CR diet for 2 weeks, followed by 52.2 kcal per week of CR diet for 6 weeks.  The remaining dietary groups were fed the control diets containing, respectively, metformin (MET; Sigma, St. Louis, MO), glipizide (GLIP; Sigma), MET plus GLIP, rosiglitazone (ROS; Avandia, SmithKline Beecham) or soy isoflavone extract (SOY; NOVASOY 400, Life Extension Foundation) for 8 weeks at the dosages indicated in Table 1.  The drugs were mixed with powdered control diet and cold-pressed into one gram pellets (BIO-SERV Inc.).  At 0900, all mice were fed 2/7 of the weekly allotment of food on Monday and Wednesday and 3/7 on Friday.  The mice had free access to acidified tap water.  They were fasted for 48 hours and killed by cervical dislocation at 22 months of age.  No signs of pathology were detected in the animals used for the studies reported (n=4 per group).  Organs were removed rapidly, flash frozen, and stored in liquid nitrogen.  The weights of the mice were monitored bi-weekly.  Mouse weights are given in Table 1.
Measurement of specific mRNA levels.  Liver total RNA was isolated as described from livers of pathology-free mice in each group (n=4 per group) (13). mRNA levels were measured using Affymetrix mouse U74Av2 arrays according to standard Affymetrix protocols (Affymetrix).
Keywords = CR mimetics
Keywords = microarray profiling
Keywords = drug discovery
Keywords = gene-expression biomarkers


title: CON 3


title: LTCR2


title: HIF-1 Control Hypoxia 6

status: Public on Mar 08 2006

city: Bern

first: Christoph

last: Däpp

department: Functional Anatomy

institute: University of Bern

description: Control animal exposed to 10.5% O2 for 24 hours; female HIF-1 alpha heterozygote mouse; RNA was isolated form cryosections using RNeasy kit (Qiagen). 0.75 microgramm total RNA was subjected to microarray analysis

source_name: Soleus muscle


title: HIF-1 Control Hypoxia 4


title: HIF-1 Control Hypoxia 1


title: HIF-1 Control Hypoxia 3


title: HIF-1 Control Normoxia 6

description: Control animal; female HIF-1 alpha heterozygote mouse; RNA was isolated form cryosections using RNeasy kit (Qiagen). 0.75 microgramm total RNA was subjected to microarray analysis


title: HIF-1 Control Normoxia 3


title: HIF-1 Control Normoxia 5


title: HIF-1 Control Normoxia 4


title: HIF-1 Control Hypoxia 2


title: HIF-1 Control Normoxia 2


title: HIF-1 Control Hypoxia 5


title: wt R Hyp 6

description: Hindlimb suspension for 7 days, reloading for 24 hours in 10.5% O2; female mouse; RNA was isolated form cryosections using RNeasy kit (Qiagen). 1.5 microgramm total RNA was subjected to microarray analysis

source_name: C57Bl/6 mouse soleus muscle


title: wt R Hyp 5


title: wt R Hyp 4


title: HIF-1 Control Normoxia 1


title: wt C Hyp 6

description: Control female mouse exposed to 10.5% O2 for 24 hours; RNA was isolated form cryosections using RNeasy kit (Qiagen). 1.5 microgramm total RNA was subjected to microarray analysis


title: wt R Hyp 2


title: wt R Hyp 3


title: wt C Hyp 3


title: wt C Hyp 4


title: wt C Hyp 2


title: wt R Hyp 1


title: wt C Hyp 5


title: wt C Hyp 1


title: GC13_skin_5dpn_3

status: Public on Mar 07 2006

city: Charleston

first: Alexander

last: Awgulewitsch

state: SC

address: 173 Ashley Ave

institute: Medical University of South Carolina

description: total skin from Hoxc13-overexpressing transgenic mice (GC13) 5 days post natal

source_name: skin total


title: GC13_skin_5dpn_2


title: FVB_skin_5dpn_2

description: total skin from FVB mice 5 days post natal


title: FVB_skin_5dpn_3


title: 2.8_pSRa_tg_dex

status: Public on Feb 25 2006

city: Essen

first: Ludger

last: Klein-Hitpass

address: Virchowstr. 173

department: Universitaetsklinikum

country: Germany

institute: Institut fuer Zellbiologie

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from dexamethasone induced pSRa-p210-tkneo transformed cells from  vav-Gfi1b transgenic mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone

source_name: BCR-Abl (p210) transformed murine B-cells


title: 2.6_pSRa_wt_dex

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from dexamethasone induced pSRa-p210-tkneo transformed cells from wild type mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: 1.6_pSRa_wt_dex


title: 1.7_pSRa_tg_co

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from non-induced pSRa-p210-tkneo transformed cells from vav-Gfi1b transgenic mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: 2.1_MSCV_wt_co

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from non-induced MSCV-GFP-IRESp210 transformed cells from wild type mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: 1.1_MSCV_wt_co

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from non-induced MSCV-GFP-IRESp210 transformed wild type cells.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: GLIP1


title: 2.5_pSRa_wt_co

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from non-induced pSRa-p210-tkneo transformed cells from wild type mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: 1.5_pSRa_wt_co


title: 1.4_MSCV_tg_dex

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from dexamethasone induced MSCV-GFP-IRESp210 transformed cells from vav-Gfi1b transgenic mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: 2.2_MSCV_wt_dex

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from dexamethasone induced MSCV-GFP-IRESp210 transformed cells from wild type mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: 1.3_MSCV_tg_co

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from non-induced MSCV-GFP-IRESp210 transformed cells from vav-Gfi1b transgenic mice.
Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: FVB_skin_5dpn_1


title: 2.4_MSCV_tg_dex


title: 2.3_MSCV_tg_co

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from non-induced MSCV-GFP-IRESp210 transformed cells from vav-Gfi1b transgenic mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: Breast Cancer 96

status: Public on Feb 18 2006

city: Singapore

first: Kun

last: Yu

department: Cellular & Molecular Research

country: Singapore

institute: National Cancer Centre

description: Prime invasive breast tumor sample

source_name: Breast tumor


title: 1.8_pSRa_tg_dex

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from dexamethasone induced pSRa-p210-tkneo transformed cells from vav-Gfi1b transgenic mice.

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: 1.2_MSCV_wt_dex

description:
For generation of pre-B cell lines, bone marrow from tibias and femurs of 4 to 8 week old C56Bl/6 mice (wt and vav-Gfi1b transgene) was infected with retroviral stocks of different BCR-Abl constructs (MSCV-GFP-IRESp210 or pSRa-p210-tkneo) and plated at a density of 5E+06 per 6 cm dish. All pre-B cells were fed twice a week and analyzed after they became stroma independent. Cells received 1E-08 M dexamethasone or vehicle for 12 hours prior to RNA extraction using TRIzol. mRNAs were converted into doublestranded cDNA using a T7-promoter tagged oligodT primer and transcribed by T7 RNA polymerase in the presence of biotinylated NTPs. Targets were hybridized to Affymetrix MOE430A arrays, washed, stained and scanned (GeneChip scanner 2500) as recommended by the manufacturer. Images were processed either by MAS5.0 (global scaling, TGT=1000) or RMAExpress (quantile normalization and background substraction) software tools.
By comparing the gene expression profiles of dexamethasone and non-induced cells, dexamethasone target genes were identified. This entry corresponds to the RNA isolated from dexamethasone induced MSCV-GFP-IRESp210 transformed wild type cells

Keywords = B-cell
Keywords = BCR-Abl
Keywords = Gfi1b
Keywords = dexamethasone


title: Breast Cancer 95

description: Prime invasive breast tumor sample


title: 2.7_pSRa_tg_co


title: Breast Cancer 94

description: Prime invasive breast tumor sample


title: GC13_skin_5dpn_1


title: Breast Cancer 93

description: Prime invasive breast tumor sample


title: Breast Cancer 91

description: Prime invasive breast tumor sample


title: Breast Cancer 92

description: Prime invasive breast tumor sample


title: Breast Cancer 90

description: Prime invasive breast tumor sample


title: Breast Cancer 88

description: Prime invasive breast tumor sample


title: Breast Cancer 87

description: Prime invasive breast tumor sample


title: C57 whole brain 2

description:
Whole brain was obtained from five 10 week old naive C57BL/2 male mice  and four 10 week old naive DBA/2J mice.  Total RNA was extracted using a Quiagen RNeasy kit midi kits for lipid rich tissues. Target cRNA were produced using standard Affymetrix procedures from 5 ug of total RNA.
This sample is also known as C57 1.
Keywords = Mus musculus, inbred strains, whole brain gene expression pattern


title: Breast Cancer 86

description: Prime invasive breast tumor sample


title: Breast Cancer 85

description: Prime invasive breast tumor sample


title: Breast Cancer 83

description: Prime invasive breast tumor sample


title: Breast Cancer 77

description: Prime invasive breast tumor sample


title: Breast Cancer 79

description: Prime invasive breast tumor sample


title: Breast Cancer 72

description: Prime invasive breast tumor sample


title: Breast Cancer 80

description: Prime invasive breast tumor sample


title: Breast Cancer 82

description: Prime invasive breast tumor sample


title: Breast Cancer 75

description: Prime invasive breast tumor sample


title: Breast Cancer 73

description: Prime invasive breast tumor sample


title: Breast Cancer 67

description: Prime invasive breast tumor sample


title: Breast Cancer 69

description: Prime invasive breast tumor sample


title: Breast Cancer 71

description: Prime invasive breast tumor sample


title: Breast Cancer 76

description: Prime invasive breast tumor sample


title: Breast Cancer 74

description: Prime invasive breast tumor sample


title: Breast Cancer 66

description: Prime invasive breast tumor sample


title: Breast Cancer 64

description: Prime invasive breast tumor sample


title: Breast Cancer 81

description: Prime invasive breast tumor sample


title: Breast Cancer 78

description: Prime invasive breast tumor sample


title: Breast Cancer 68

description: Prime invasive breast tumor sample


title: Breast Cancer 84

description: Prime invasive breast tumor sample


title: Breast Cancer 65

description: Prime invasive breast tumor sample


title: Breast Cancer 62

description: Prime invasive breast tumor sample


title: Breast Cancer 70

description: Prime invasive breast tumor sample


title: Breast Cancer 63

description: Prime invasive breast tumor sample


title: Breast Cancer 61

description: Prime invasive breast tumor sample


title: Breast Cancer 89

description: Prime invasive breast tumor sample


title: Breast Cancer 58

description: Prime invasive breast tumor sample


title: Breast Cancer 59

description: Prime invasive breast tumor sample


title: Breast Cancer 56

description: Prime invasive breast tumor sample


title: Breast Cancer 54

description: Prime invasive breast tumor sample


title: Breast Cancer 52

description: Prime invasive breast tumor sample


title: Breast Cancer 60

description: Prime invasive breast tumor sample


title: Breast Cancer 57

description: Prime invasive breast tumor sample


title: Breast Cancer 49

description: Prime invasive breast tumor sample


title: Breast Cancer 51

description: Prime invasive breast tumor sample


title: Breast Cancer 44

description: Prime invasive breast tumor sample


title: Breast Cancer 55

description: Prime invasive breast tumor sample


title: Breast Cancer 45

description: Prime invasive breast tumor sample


title: Breast Cancer 53

description: Prime invasive breast tumor sample


title: Breast Cancer 50

description: Prime invasive breast tumor sample


title: Breast Cancer 46

description: Prime invasive breast tumor sample


title: Breast Cancer 35

description: Prime invasive breast tumor sample


title: Breast Cancer 40

description: Prime invasive breast tumor sample


title: Breast Cancer 34

description: Prime invasive breast tumor sample


title: Breast Cancer 42

description: Prime invasive breast tumor sample


title: Breast Cancer 41

description: Prime invasive breast tumor sample


title: Breast Cancer 39

description: Prime invasive breast tumor sample


title: Breast Cancer 47

description: Prime invasive breast tumor sample


title: Breast Cancer 31

description: Prime invasive breast tumor sample


title: Breast Cancer 33

description: Prime invasive breast tumor sample


title: Breast Cancer 30

description: Prime invasive breast tumor sample


title: Breast Cancer 38

description: Prime invasive breast tumor sample


title: Breast Cancer 36

description: Prime invasive breast tumor sample


title: Breast Cancer 48

description: Prime invasive breast tumor sample


title: Breast Cancer 32

description: Prime invasive breast tumor sample


title: Breast Cancer 17

description: Prime invasive breast tumor sample


title: Breast Cancer 25

description: Prime invasive breast tumor sample


title: Breast Cancer 26

description: Prime invasive breast tumor sample


title: Breast Cancer 18

description: Prime invasive breast tumor sample


title: Breast Cancer 27

description: Prime invasive breast tumor sample


title: Breast Cancer 29

description: Prime invasive breast tumor sample


title: Breast Cancer 28

description: Prime invasive breast tumor sample


title: Breast Cancer 22

description: Prime invasive breast tumor sample


title: Breast Cancer 15

description: Prime invasive breast tumor sample


title: Breast Cancer 23

description: Prime invasive breast tumor sample


title: Breast Cancer 12

description: Prime invasive breast tumor sample


title: Breast Cancer 20

description: Prime invasive breast tumor sample


title: Breast Cancer 14

description: Prime invasive breast tumor sample


title: Breast Cancer 16

description: Prime invasive breast tumor sample


title: Breast Cancer 24

description: Prime invasive breast tumor sample


title: Breast Cancer 21

description: Prime invasive breast tumor sample


title: Breast Cancer 5

description: Prime invasive breast tumor sample


title: Breast Cancer 43

description: Prime invasive breast tumor sample


title: Breast Cancer 6

description: Prime invasive breast tumor sample


title: Breast Cancer 13

description: Prime invasive breast tumor sample


title: Breast Cancer 19

description: Prime invasive breast tumor sample


title: Breast Cancer 8

description: Prime invasive breast tumor sample


title: Breast Cancer 11

description: Prime invasive breast tumor sample


title: Breast Cancer 9

description: Prime invasive breast tumor sample


title: Breast Cancer 4

description: Prime invasive breast tumor sample


title: Breast Cancer 10

description: Prime invasive breast tumor sample


title: Breast Cancer 2

description: Prime invasive breast tumor sample


title: Breast Cancer 3

description: Prime invasive breast tumor sample


title: n7t6so

status: Public on Feb 15 2006

city: Bethesda

first: Robert

middle: L

last: Danner

address: 10 Center Drive

department: Critical Care Medicine Department

institute: Clinical Center

description: Differentiated cells (100 nanomolar phorbol 12-myristate 13-acetate for 48 h) treated with S-nitrosoglutathione (400 micromolar) for 6 h.  Total RNA was isolated using RNeasy Mini Kit and Qiashredder column.  Targets were produced using standard Affymetrix procedures from 10 micrograms of total RNA.

source_name: U937 cells; Human monoblastoid line devoid of guanylate cyclase


title: Breast Cancer 37

description: Prime invasive breast tumor sample


title: Breast Cancer 7

description: Prime invasive breast tumor sample


title: n6t6so


title: n7t6go

description: Differentiated cells (100 nanomolar phorbol 12-myristate 13-acetate for 48 h) treated with glutathione (400 micromolar) for 6 h.  Total RNA was isolated using RNeasy Mini Kit and Qiashredder column.  Targets were produced using standard Affymetrix procedures from 10 micrograms of total RNA.


title: n7t0p

description: Differentiated cells (100 nanomolar phorbol 12-myristate 13-acetate for 48 h).  Total RNA was isolated using RNeasy Mini Kit and Qiashredder column.  Targets were produced using standard Affymetrix procedures from 10 micrograms of total RNA.


title: n6t6sc

description: Differentiated cells (100 nanomolar phorbol 12-myristate 13-acetate for 48 h) treated with S-nitrosoglutathione (400 micromolar) plus dibutyryl cAMP (100 micromolar) for 6 h.  Total RNA was isolated using RNeasy Mini Kit and Qiashredder column.  Targets were produced using standard Affymetrix procedures from 10 micrograms of total RNA.


title: Breast Cancer 1

description: Prime invasive breast tumor sample


title: n5t0p


title: n7t6gc

description: Differentiated cells (100 nanomolar phorbol 12-myristate 13-acetate for 48 h) treated with glutathione (400 micromolar) plus dibutyryl cAMP (100 micromolar) for 6 h.  Total RNA was isolated using RNeasy Mini Kit and Qiashredder column.  Targets were produced using standard Affymetrix procedures from 10 micrograms of total RNA.


title: n5t6gc


title: n6t6gc


title: n5t6sc


title: n6t6go


title: n4t6so


title: n4t0p


title: n7t6sc


title: n5t6so


title: n4t6go


title: n3t6sc


title: n3t6so


title: n4t6gc


title: n5t6go


title: n3t6gc


title: n2t6so


title: n3t6go


title: n4t6sc


title: n6t0p


title: n3t0p


title: n2t6sc


title: n2t6go


title: n1t6sc


title: n1t6gc


title: n2t6gc


title: n1t0p


title: n1t6go


title: n1t6so


title: Actinomycin D_24h_global

status: Public on Feb 04 2006

description:
HT1080 fibrosarcoma cells were treated with cytostatic drugs and analysed on Affymetrix microarray to identify genes and pathways regulated by these compounds. This entry corresponds to cells treated with actinomycin D for 24h. The array image was processed using Affymetrix MAS 5.0 software and normalized by global scaling.
Keywords = Actinomycin D
Keywords = cytostatic drugs
Keywords = apoptosis

source_name: HT1080 fibrosarcoma


title: Vincristine_24h_global

description:
HT1080 fibrosarcoma cells were treated with cytostatic drugs and analysed on Affymetrix microarray to identify genes and pathways regulated by these compounds. This entry corresponds to cells treated for 24 h with vincristine. The array image was processed using Affymetrix MAS 5.0 software and normalized by global scaling.
Keywords = Vincristine
Keywords = cytostatic drugs
Keywords = apoptosis


title: Doxorubicin_6h_global

description:
HT1080 fibrosarcoma cells were treated with cytostatic drugs and analysed on Affymetrix microarray to identify genes and pathways regulated by these compounds. This entry corresponds to cells treated for 6 h with doxorubicin. The array image was processed using Affymetrix MAS 5.0 software and normalized by global scaling.
Keywords = Doxorubicin
Keywords = cytostatic drugs
Keywords = apoptosis


title: Doxorubicin_24h_global

description:
HT1080 fibrosarcoma cells were treated with cytostatic drugs and analysed on Affymetrix microarray to identify genes and pathways regulated by these compounds. This entry corresponds to cells treated for 24 h with doxorubicin. The array image was processed using Affymetrix MAS 5.0 software and normalized by global scaling.
Keywords = Doxorubicin
Keywords = cytostatic drugs
Keywords = apoptosis


title: estrogen treated - Rep 1

status: Public on Feb 02 2006

city: Duarte

first: Shiuan

last: Chen

address: 1500 E Duarte Rd

department: Surgical Research

institute: City of Hope

description: estrogen treated - Rep 1

source_name: MCF-7aro cells


title: orujo

status: Public on Feb 09 2006

city: Zaragoza

first: Jesus

last: Osada

address: Miguel Servet, 177

country: Spain

institute: Universidad de Zaragoza

description:
Animals were fed a high fat diet enriched in olive oil unsaponifiable fraction. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA.

Keywords = liver. High fat diet. Olive oil.

source_name: liver from animals lacking apolipoprotein E


title: A + tamoxifen - Rep 1

description: androgen + tamoxifen - Rep 1


title: olive

description:
Animals were fed a high fat diet enriched in olive oil. RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA.

Keywords = liver. High fat diet. Olive oil.


title: estrogen treated - Rep 2

description: estrogen treated - Rep 2


title: A + tamoxifen - Rep 2

description: androgen + tamoxifen - Rep 2


title: Control_spikenormalized

description:
HT1080 fibrosarcoma cells were treated with cytostatic drugs and analysed on Affymetrix microarray to identify genes and pathways regulated by these compounds. This entry corresponds to untreated control cells. The array image was processed using Affymetrix MAS 5.0 software and normalized to a mask file representing polyA+ spike controls.
Keywords = Cytostatic drugs
Keywords = apoptosis


title: estrogen treated - Rep 3

description: estrogen treated - Rep 3


title: Actinomycin D_24h_spikenormalized

description:
HT1080 fibrosarcoma cells were treated with cytostatic drugs and analysed on Affymetrix microarray to identify genes and pathways regulated by these compounds. This entry corresponds to cells treated for 24h with actinomycin D. The array image was processed using Affymetrix MAS 5.0 software and normalized to a mask file representing polyA+ spike controls.
Keywords = Actinomycin D
Keywords = cytostatic drugs
Keywords = apoptosis


title: A + tamoxifen - Rep 3

description: androgen + tamoxifen - Rep 3


title: Control_global

description:
HT1080 fibrosarcoma cells were treated with cytostatic drugs and analysed on Affymetrix microarray to identify genes and pathways regulated by these compounds. This entry corresponds to an untreated control. The array image was processed using Affymetrix MAS 5.0 software and normalized by global scaling.
Keywords = Cytostatic drugs
Keywords = apoptosis


title: A + letrozole - Rep 2

description: androgen + letrozole (CGS) - Rep 2


title: control - Rep 3

description: untreated control (vehicle) - Rep 3


title: A + letrozole - Rep 3

description: androgen + letrozole (CGS) - Rep 3


title: control - Rep 2

description: untreated control (vehicle) - Rep 2


title: A + letrozole - Rep 1

description: androgen + letrozole (CGS) - Rep 1


title: A + anastrozole - Rep 3

description: androgen + anastrozole (CGP) - Rep 3


title: A + anastrozole - Rep 2

description: androgen + anastrozole (CGP) - Rep 2


title: Hypoxia HIF-1alpha null sample N3

status: Public on Jan 28 2006

city: La Jolla

first: Jared

last: Allen

address: 9500 Gilman Drive, 0412

department: Bioengineering

institute: University of California, San Diego

description: Hypoxia treated sample (HIF-1alpha null) for evaluation of hypoxic response in hepatocytes

source_name: hepatocytes


title: A + anastrozole - Rep 1

description: androgen + anastrozole (CGP) - Rep 1


title: androgen treated - Rep 2

description: androgen treated - Rep 2


title: control - Rep 1

description: untreated control (vehicle) - Rep 1


title: androgen treated - Rep 1

description: androgen treated - Rep 1


title: Hypoxia HIF-1alpha null sample N2


title: androgen treated - Rep 3

description: androgen treated - Rep 3


title: Hypoxia HIF-1alpha null sample N1


title: Hypoxia Adeno treated sample N1

description: Hypoxia adeno treated sample (wild type) for evaluation of hypoxic response in hepatocytes


title: Normoxic Adeno treated Control N1

description: Normoxic adeno treated control for evaluation of hypoxic response in hepatocytes


title: Hypoxia Adeno Treated Sample N3


title: Normoxic Adeno Treated Control N2


title: WT, PR01M004v0

status: Public on Jan 27 2006

city: Indianapolis

first: Peter

last: Roach

state: IN

institute: IU School of Medicine

description:
OrganismPart:Muscle;StrainOrLine:C57BL6/129SV; Anterior tibialis removed from 3-month old muscle glycogen synthase WT or knockout mouse. RNA was extracted using GibcoBRL TRIzol Reagent and a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.
Sample_series_id: GSE2198

source_name: Anterior tibialis


title: Normoxic Control N2

description: Normoxic untreated control for evaluation of hypoxic response in hepatocytes


title: Hypoxia Adeno Treated Sample N2


title: GSL30, PR04M005v0

description: Medial gastrocnemius removed from 8-month old muscle glycogen synthase WT or overexpressing mouse. RNA was extracted using GibcoBRL TRIzol Reagent and a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.

source_name: medial gastrocnemius


title: n2t0p

description: Differentiated cells (100 nanomolar phorbol 12-myristate 13-acetate for 48 h).  Total RNA was isolated using RNeasy Mini Kit and Qiashredder column.  Targets were produced using standard Affymetrix procedures from 10 micrograms of total RNA.


title: WT, PR04M004v0


title: Normoxic Control N1


title: GSL30, PR04M010v0


title: WT, PR03M004v0

description: Medial gastrocnemius removed from 3-month old muscle glycogen synthase WT or knockout mouse. RNA was extracted using GibcoBRL TRIzol Reagent and a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.


title: WT, PR04M002v0


title: WT, PR04M009v0


title: GSL30, PR04M008v0


title: MGSKO, PR03M008v0


title: GSL30, PR04M006v0


title: WT, PR04M001v0


title: MGSKO, PR02M007v0

description: Liver removed from 3-month old muscle glycogen synthase WT or knockout mouse. RNA was extracted using GibcoBRL TRIzol Reagent and a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.

source_name: Liver


title: WT, PR03M005v0


title: WT, PR03M001v0


title: MGSKO, PR02M008v0


title: GSL30, PR04M007v0


title: WT, PR03M003v0


title: WT, PR03M002v0


title: WT, PR04M003v0


title: MGSKO, PR03M006v0


title: WT, PR02M003v0


title: WT, PR02M002v0


title: MGSKO, PR03M007v0


title: WT, PR02M005v0


title: WT, PR02M004v0


title: MGSKO, PR02M006v0


title: MGSKO, PR02M001v0


title: MGSKO, PR01M007v0

description: OrganismPart:Muscle;StrainOrLine:C57BL6/129SV; Anterior tibialis removed from 3-month old muscle glycogen synthase WT or knockout mouse. RNA was extracted using GibcoBRL TRIzol Reagent and a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.


title: MGSKO, PR01M008v0


title: MGSKO, PR01M005v0


title: WT, PR01M002v0


title: WT, PR01M003v0


title: MGSKO, PR01M006v0


title: 208c: AEC II- AEC I

status: Public on Jan 14 2006

city: Stillwater

first: Zhongming

state: OK

address: 264 McElroy Hall

department: Deptment of Physiological Sciences

institute: Oklahoma State University

description: Freshly isolated alveolar epithelial cells (AEC) type I and II were monitored for transcriptome with DNA microarray hybridization using 3DNA 50 version 2 kit.

source_name: AEC II

source_name: AEC I


title: WT, PR01M001v0


title: 207c: AEC I- AEC II


title: 207b: AEC I- AEC II


title: 208b: AEC II -AEC I


title: 206b: AEC II -AEC I


title: 205c: AEC I- AEC II


title: 207a: AEC I- AEC II


title: 107c: AEC II- AEC I


title: 205b: AEC I- AEC II


title: 208a: AEC II -AEC I


title: 206a: AEC II -AEC I


title: 108c: AEC I- AEC II


title: 204b-AEC II- AEC I


title: 107b: AEC II- AEC I


title: 106b: AEC I- AEC II


title: 109b: AEC II-AEC I


title: 204c-AEC II- AEC I


title: 204a-AEC II- AEC I


title: 109c: AEC II-AEC I


title: 107a: AEC II- AEC I


title: 108a: AEC I- AEC II


title: 105c: AEC II-AEC I


title: 105b: AEC II-AEC I


title: 108b: AEC I- AEC II


title: 205a: AEC I- AEC II


title: 109a: AEC II-AEC I


title: 106c: AEC I-AEC II


title: 105a: AEC II-AEC I


title: 106a: AEC I- AEC II